|
Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance). |
|
|
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Roche |
Research Funding - Genentech/Roche |
Travel, Accommodations, Expenses - Genentech/Roche |
|
|
No Relationships to Disclose |
|
|
Employment - Genentech/Roche |
Research Funding - Genentech/Roche |
|
|
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; Immunovative Therapies; kanghong Pharma; Merck; Merrimack; Momenta Pharmaceuticals; Novo Nordisk; Pfizer; Sirtex Medical; Taiho Pharmaceutical; Targovax |
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi |
|
|
Honoraria - Taiho Pharmaceutical |
Consulting or Advisory Role - CASI Pharmaceuticals |
|
|
No Relationships to Disclose |
|
|
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst) |
|
|
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical |
|
|
No Relationships to Disclose |
|
|
Honoraria - Gilead Sciences |
Consulting or Advisory Role - Gilead Sciences; Merrimack |
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Serono (Inst) |
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Merck Serono; Merrimack; Roche; Taiho Pharmaceutical |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche |
|
|
Employment - Genentech/Roche |
Stock and Other Ownership Interests - Roche |
Research Funding - Genentech/Roche |
Patents, Royalties, Other Intellectual Property - Dana Farber Cancer Hospital; Genentech/Roche |
Travel, Accommodations, Expenses - Genentech/Roche |